GlassScriptPhysician profile
Gregory S Martin
NPI 1891875423
$11,831.60
in general payments reported to CMS, 2019-2025
28 companies · $279 in 2025
The $279 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $388 · 2020: $3,584 · 2021: $89.80 · 2022: $133 · 2023: $3,702 · 2024: $3,656 · 2025: $279.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,304 · Consulting Fee: $3,265 · Food and Beverage: $968 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,303.66 |
| Consulting Fee | $3,264.80 |
| Food and Beverage | $968.29 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols, S.A. | $10,092.26 | 2020-2024 | Albutein |
| Bayer Healthcare Pharmaceuticals INC. | $258.36 | 2019-2025 | |
| Astellas Pharma US INC | $209.44 | 2023-2025 | Veozah |
| Coopersurgical, INC. | $139.46 | 2019-2024 | Paragard T 380a, Paragard T 380a |
| Abbvie INC. | $136.88 | 2019-2023 | |
| Biogen, INC. | $127.77 | 2024-2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $114.22 | 2023-2024 | Myfembree |
| Hologic Sales and Service, LLC | $84.70 | 2023-2024 | Aptima, Acessa Provu System, Thinprep 2000 Processor |
| Mayne Pharma Commercial LLC | $74.72 | 2023-2025 | |
| Allergan, INC. | $68.41 | 2019-2020 | |
| Novo Nordisk INC | $67.56 | 2019-2023 | Saxenda, Wegovy |
| Alydia Health | $62.00 | 2021 | |
| Roche Diagnostics Corporation | $52.29 | 2019 | |
| Organon LLC | $38.23 | 2024 | |
| Daiichi Sankyo INC. | $33.14 | 2020 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $31.58 | 2024-2025 | |
| Avanos Medical | $27.80 | 2021 | |
| Amag Pharmaceuticals, INC. | $25.61 | 2019-2020 | |
| Convatec INC. | $23.99 | 2023 | |
| Innovation Technologies INC | $23.50 | 2025 | Irrisept |
| Heron Therapeutics, INC. | $19.56 | 2022 | |
| Therapeuticsmd, INC. | $19.54 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $19.47 | 2019 | |
| Scynexis, INC. | $18.61 | 2022 | |
| Lilly USA, LLC | $18.40 | 2024 | Zepbound |
| Exeltis, USA INC. | $17.53 | 2022 | |
| Myovant Sciences INC. | $15.88 | 2022 | |
| Molnlycke Health Care US, LLC | $10.69 | 2024 | Mepilex Border Post-Op Ag |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Martin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.